Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Fructosamine and Triglycerides - Developing an Index for Assessing Insulin Resistance

View ORCID ProfileLuís Jesuíno de Oliveira Andrade, View ORCID ProfileGabriela Correia Matos de Oliveira, View ORCID ProfileLuísa Correia Matos de Oliveira, View ORCID ProfileLuiz Felipe Moreno de Brito, View ORCID ProfileLuís Matos de Oliveira
doi: https://doi.org/10.1101/2024.05.19.24307591
Luís Jesuíno de Oliveira Andrade
1Departamento de Saúde da Universidade Estadual de Santa Cruz - Ilhéus - Bahia - Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luís Jesuíno de Oliveira Andrade
  • For correspondence: luis_jesuino{at}yahoo.com.br
Gabriela Correia Matos de Oliveira
2Médica pela Faculdade de Medicina UniFTC - Salvador - Bahia - Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriela Correia Matos de Oliveira
Luísa Correia Matos de Oliveira
3Centro Universitário SENAI CIMATEC - Salvador - Bahia - Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luísa Correia Matos de Oliveira
Luiz Felipe Moreno de Brito
4Laboratório de Análises e Pesquisas – Itabuna – Bahia – Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luiz Felipe Moreno de Brito
Luís Matos de Oliveira
5Escola Bahiana de Medicina e Saúde Pública - Salvador - Bahia - Brasil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luís Matos de Oliveira
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction Insulin resistance (IR) is a metabolic condition where cells become less responsive to insulin, affecting glucose absorption and leading to diseases like type 2 diabetes. Factors like obesity and high triglycerides worsen IR. Fructosamine is a key marker for short-term glycemic control and can indicate IR. Various methods, like the euglycemic clamp and HOMA-IR index, assess IR, with the TyG index emerging as a simple and reliable tool due to its strong correlation with IR.

Objective To develop and evaluate a novel IR index that incorporates both fructosamine and triglyceride levels, aiming to improve the accuracy of IR assessment compared to existing methods.

Methods This study investigated IR using established methods and proposed a novel TrigFruc index incorporating fructosamine. Data from 200 individuals was analyzed to assess the TrigFruc index’s performance compared to existing methods (HOMA-IR and TyG index). Descriptive statistics summarized participant demographics, and Pearson’s correlation evaluated the relationship between TrigFruc and HOMA-IR and between TrigFruc and TyG index. A receiver operating characteristic (ROC) analysis identified the optimal TrigFruc cut-off point for IR detection, comparing its sensitivity and specificity to HOMA-IR and TyG index.

Results Study with 200 participants (63% female, avg. age 46.6 years), the established HOMA-IR index identified IR in 32% (64 individuals) while the TyG index found it in 66% (132). The new TrigFruc index showed a weaker correlation with HOMA-IR (r=0.28) compared to the TyG index (r=0.44). For detecting IR based on HOMA-IR, the optimal TrigFruc cut-off (Ln 4.57) had just 50% sensitivity (correctly identifying half of true IR cases) but low specificity (23%, high misclassification of non-IR cases). When compared to the TyG index, the optimal TrigFruc cut-off (Ln 4.74) showed excellent performance with high sensitivity (85%, strong ability to identify true IR) and specificity (95%, low misclassification of non-IR).

Conclusion The TrigFruc index, incorporating fructosamine, shows promise for IR assessment. Compared to HOMA-IR, it exhibits better correlation with the TyG index and superior sensitivity and specificity for IR detection when using the TyG index as a reference.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research adhered to the ethical principles outlined in the Declaration of Helsinki. The project received approval from the National Commission for Research Ethics in Brazil (CONEP), with a registry number of 2,464,513. To safeguard patient privacy, we implemented rigorous protocols for data confidentiality and protection.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 20, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Fructosamine and Triglycerides - Developing an Index for Assessing Insulin Resistance
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Fructosamine and Triglycerides - Developing an Index for Assessing Insulin Resistance
Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luísa Correia Matos de Oliveira, Luiz Felipe Moreno de Brito, Luís Matos de Oliveira
medRxiv 2024.05.19.24307591; doi: https://doi.org/10.1101/2024.05.19.24307591
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Fructosamine and Triglycerides - Developing an Index for Assessing Insulin Resistance
Luís Jesuíno de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Luísa Correia Matos de Oliveira, Luiz Felipe Moreno de Brito, Luís Matos de Oliveira
medRxiv 2024.05.19.24307591; doi: https://doi.org/10.1101/2024.05.19.24307591

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Endocrinology (including Diabetes Mellitus and Metabolic Disease)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)